Published in Exp Ther Med on April 05, 2012
Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. J Natl Cancer Inst (2014) 2.28
Breast cancer as a systemic disease: a view of metastasis. J Intern Med (2013) 1.55
CTC enumeration and characterization: moving toward personalized medicine. Ann Transl Med (2014) 0.94
MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells. Exp Ther Med (2014) 0.85
Circulating tumour cells in breast cancer. Ecancermedicalscience (2013) 0.84
Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells. Exp Ther Med (2014) 0.82
Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis. Sci Rep (2017) 0.75
Circulating Tumor Cell Isolation and Analysis. Adv Clin Chem (2016) 0.75
Characterization of DNA Methylation in Circulating Tumor Cells. Genes (Basel) (2015) 0.75
The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer. Oncotarget (2016) 0.75
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med (2004) 27.92
Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer (2007) 6.58
Dissecting the metastatic cascade. Nat Rev Cancer (2004) 6.32
Seeding and propagation of untransformed mouse mammary cells in the lung. Science (2008) 5.33
Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res (2004) 4.48
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol (2008) 3.64
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin Cancer Res (2010) 2.66
Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res (2008) 2.16
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Res Treat (2009) 1.93
Molecular mechanisms of metastasis in breast cancer--clinical applications. Nat Rev Clin Oncol (2010) 1.83
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol (2009) 1.71
Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology (2008) 1.47
Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int J Cancer (2003) 1.28
Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas. Mod Pathol (2009) 1.22
Disseminated and circulating tumor cells: Role in effective cancer management. Crit Rev Oncol Hematol (2010) 1.20
Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res (2007) 1.19
Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Breast Cancer Res Treat (2006) 1.04
Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer. Cancer Biol Ther (2009) 0.95
Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression. Patholog Res Int (2011) 0.94
Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy. J Cancer Res Clin Oncol (2010) 0.92
Neoadjuvant systemic treatment of breast cancer. J Surg Oncol (2011) 0.85
Circulating tumour cells in locally advanced breast cancer. Clin Transl Oncol (2009) 0.85
Circulating tumour cells in peripheral blood: potential impact on breast cancer outcome. Clin Transl Oncol (2011) 0.77
Pulmonary vascular dysfunction induced by high tidal volume mechanical ventilation. Crit Care Med (2013) 1.54
Biomarkers characterization of circulating tumour cells in breast cancer patients. Breast Cancer Res (2012) 1.13
Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum (2007) 1.12
The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. J Clin Rheumatol (2007) 1.09
Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum (2006) 1.08
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum (2005) 1.05
CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy. Int J Cancer (2013) 1.05
Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol (2011) 1.01
Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: latest advances towards an integrated approach. Cancer Treat Rev (2010) 0.89
Long-term outcome of patients with vasovagal syncope. Am Heart J (2004) 0.87
A new locus for resistance to gamma-radiation-induced thymic lymphoma identified using inter-specific consomic and inter-specific recombinant congenic strains of mice. Oncogene (2002) 0.87
Guatemala mestizo population data on 15 STR loci (Identifiler Kit). J Forensic Sci (2006) 0.85
Characterization of human control region sequences for Spanish individuals in a forensic mtDNA data set. Leg Med (Tokyo) (2007) 0.85
Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty. Am Heart J (2007) 0.83
Conformational changes in azurin from Pseudomona aeruginosa induced through chemical and physical protocols. Biophys J (2004) 0.83
Assessment of HV1 and HV2 mtDNA variation for forensic purposes in an Uruguayan population sample. J Forensic Sci (2005) 0.83
Results of the 2003-2004 GEP-ISFG collaborative study on mitochondrial DNA: focus on the mtDNA profile of a mixed semen-saliva stain. Forensic Sci Int (2005) 0.83
Impact of diet on breast cancer risk: a review of experimental and observational studies. Crit Rev Food Sci Nutr (2013) 0.82
Current trends in solid-phase-based extraction techniques for the determination of pesticides in food and environment. J Biochem Biophys Methods (2006) 0.82
Transcriptional shift identifies a set of genes driving breast cancer chemoresistance. PLoS One (2013) 0.80
Effects of four carbamate compounds on antioxidant parameters. Ecotoxicol Environ Saf (2008) 0.80
Type 1 diabetes-induced hyper-responsiveness to 5-hydroxytryptamine in rat pulmonary arteries via oxidative stress and induction of cyclooxygenase-2. J Pharmacol Exp Ther (2011) 0.79
Stratification by age of onset with 30 years as age limit is an effective means of identifying PSORS1-associated psoriasis in patients with psoriatic arthritis. Joint Bone Spine (2011) 0.79
[Quality of life in patients with vasovagal syncope. Clinical parameters influence]. Med Clin (Barc) (2003) 0.79
Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients? Antioxid Redox Signal (2011) 0.79
Assessment of pesticide residues in honey samples from portugal and Spain. J Agric Food Chem (2003) 0.79
Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico. Rheumatology (Oxford) (2009) 0.79
Entheseal ultrasound abnormalities in patients with SAPHO syndrome. Clin Rheumatol (2012) 0.78
Advanced breast cancer: chemotherapy phase III trials that change a standard. Anticancer Drugs (2007) 0.78
Mexican population data on fifteen STR loci (Identifiler kit) in a Chihuahua (North Central Mexico) sample. J Forensic Sci (2005) 0.78
Circulating tumour cells in peripheral blood: potential impact on breast cancer outcome. Clin Transl Oncol (2011) 0.77
Exemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II study. Clin Breast Cancer (2010) 0.76
Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. Arthritis Rheum (2006) 0.75
A genetic population study of six Y STRS (Y-Plex6) in an Uruguayan sample and its comparison with other populations. J Forensic Sci (2005) 0.75
Association of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: comment on the article by Frostegård et al. Arthritis Rheum (2006) 0.75
Cutaneous apocrine cystic adenolipoma. Am J Dermatopathol (2005) 0.75
Intentional mixed buccal cell reference sample in a paternity case. J Forensic Sci (2007) 0.75
Control of pesticide residues by liquid chromatography-mass spectrometry to ensure food safety. Mass Spectrom Rev (2006) 0.75
Population data on 15 STR loci (PowerPlex 16 kit) in a Costa Rica (Central America) sample population. J Forensic Sci (2004) 0.75
Brazilian Caucasian population data for 15 STR loci (PowerPlex 16 kit). J Forensic Sci (2004) 0.75
Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates. Free Radic Res (2011) 0.75
Proliferation determined by ki67 marker and pCR in locally advanced breast cancer patients treated with neo-adjuvant chemotherapy. Breast J (2013) 0.75
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD). Clin Transl Oncol (2005) 0.75
Open testicular biopsy without a surgical assistant using a scrotal Rumel tourniquet. J Urol (2006) 0.75
Acute Kidney Injury in Mechanically Ventilated Patients: The Risk Factor Profile Depends on the Timing of Aki Onset. Shock (2017) 0.75